Clinical Trial Update: REFLEx Study (ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance [Phase 4]

View source ↗

Summary

Phase 4 REFLEx study completed evaluating the handling and electrical performance of the Endotak Reliance G lead in arrhythmia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia

Drugs mentioned

• Endotak Reliance G Lead

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Arrhythmia | Phase 4 | Status: COMPLETED